Total Funding
55
67
Total FundingSeries B raised
Growth Score 55 in past quarter
-3 pts
Heat Score 67 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26476
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
Dean Falb: Chief Scientific OfficerPast Role: LogicBio Therapeutics, CSO- Xinyan Li: Co-Founder and CEO
About the Company
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
Women Founded